A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer - Concepedia

Concepedia

Publication | Closed Access

A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer

43

Citations

32

References

2016

Year

Rongzu Nie, Wei Zhu, Jinming Peng, Zhenzhen Ge, Chunmei Li

Alzheimer's DiseaseInsulin Amyloid FibrilBiochemistryMedicineDiabetesEgcg MonomerA-type Dimeric Epigallocatechin-3-gallateProtein MisfoldingPharmacologyInsulin SignalingDrug Discovery

References

	Year	Citations

Page 1